Jenburkt Pharmaceuticals Limited (JENBURPH) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE354A01013
Key metrics
- Market Cap
- ₹465 Cr
- P/E Ratio
- 14.47
- EPS
- 72.76
- Book Value
- 446.47
- P/B Ratio
- 2.36
- ROE
- 17.63%
- ROCE
- 20.36%
- Debt / Equity
- 0.01
- Net Margin
- 20.59%
- Revenue Growth
- 11.24%
- Profit Growth
- 8.34%
- Dividend Yield
- 1.97%
- 52W High
- ₹1,321.00
- 52W Low
- ₹944.00
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Jenburkt Pharmaceuticals Limited
Jenburkt Pharmaceuticals Limited manufactures and markets pharmaceutical formulations in India and internationally. The company offers therapeutic solutions, such as analgesic and antipyretics, anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants and antacids, aphrodisiac, atopic dermatitis, consumer division, cough and cold, muscle relaxants, neuropathic pain, nutraceuticals, and pain management. It offers its products under the Allerzine, CartiSafe Forte, Crisbo, Eberjen, ECOPROT, Frendacid, Fundu, Glajen-E, GLUCOTROL, HYBRITA, Jenflam, La-Viril, LUMA, Lubtriben, Metmin, Nervega-75, Nervijen P, Nervijen, NOCAL, Numox-625, OJEN, ORNEL, Oxicojen, PANTAZOLE, PIRITEXYL, POWERDOL, Powergesic, Rabera, Topcal-M, Trapidol-D, TREGA, TRIBEN, ZENGLOBIN, ZIX, Zix-MR, Zix-PG 200/75, and Zydol Suspension brand names. The company also exports its products. It serves large government, semi-government institutions, missionary hospitals, and public sector enterprises. Jenburkt Pharmaceuticals Limited was incorporated in 1985 and is based in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 801
- Promoter Holding
- 61.18%
The full Jenburkt Pharmaceuticals Limited analysis
Create a free account to open the complete JENBURPH deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.